HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $3 Price Target
Co-Diagnostics, Inc.
Co-Diagnostics, Inc. CODX | 0.00 |
HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:
CODX) with a Neutral and maintains $3 price target.
